ALTURiX Acquires UK rights to desmopressin oral solution
Deal is part of mission to increase options available prescribers, patients and the NHS
Read More
Tag: desmopressin
Ferring launches nocturia drug for adults of all ages
Ferring Pharmaceuticals has launched Noqdirna in the UK, offering the only licensed treatment for the symptomatic treatment of nocturia due to nocturnal polyuria in adults of all ages.
Read More
FDA panel backs Allergan’s night-time urination nasal spray
US regulatory advisors are backing clearance of Allergan’s SER120, a low-dose nasal formulation of desmopressin designed to treat night-time urination.
Read More
- Sun Pharma’s Unloxcyt now available in US for advanced cutaneous squamous cell carcinoma
- Venner Shipley announces opening of new Bristol office
- AAX Biotech and Vascurie announce new neuro-oncology collaboration
- Nxera Pharma reports positive results from phase 3 insomnia trial in South Korea
- Scottish Medicines Consortium becomes first in UK to adopt new precision gastric cancer treatment
